Aim There is a lack of an overview of the factors associated with postacute COVID-19 musculoskeletal symptoms. The aims of this study were as follows: 1- to evaluate the most frequent admission symptoms and the frequency of musculoskeletal symptoms in postacute COVID-19 patients; and 2- to determine the related factors with the postacute COVID-19 musculoskeletal symptoms. Methods A total of 280 postacute COVID-19 patients (183 females, 97 males) were enrolled and divided into two groups: 1- patients whose musculoskeletal symptoms initiated with or were aggravated by COVID-19 (n = 240); and 2- patients whose musculoskeletal symptoms did not change with COVID-19 (n = 40). The variables were demographic and treatment data, symptoms on admission, postacute COVID-19 symptoms, laboratory results (complete blood count, erythrocyte sedimentation rate, C-reactive protein, ferritin and d-dimer), chest computed tomography findings and symptoms during acute COVID-19. Results Most of the patients have fatigue (71.8%), spine pain (70.7%) and myalgia (60.7%). The most common pain region was the back (30.4%). The frequency of dyspnoea was 30%, cough 18.5% and chest pain 10.7%. Having any chronic disease (P = .031), the duration of hospital stay (P = .016), frequency of back pain during acute COVID-19 (P = .018), tomography findings and d-dimer (P = .035) levels were significantly higher, and lymphocyte (P = .024) levels were significantly lower in the patients whose symptoms began with or were aggravated by COVID-19. Conclusion Back pain was the most frequent symptom on admission. The most common postacute COVID-19 musculoskeletal symptoms were fatigue, spine pain and myalgia. Lower lymphocyte and higher d-dimer levels, the presence of COVID-19 findings in tomography and back pain during acute COVID-19 infection, higher duration of hospital stay and having chronic diseases were related to post-COVID-19 musculoskeletal symptoms.
15 December 2025 in Turkish Journal of Physical Medicine and Rehabilitation
Objectives: The aim of this study was to examine the potential effects of social support levels and different types of social support on pain and symptom severity, and quality of life in patients with fibromyalgia (FM). Patients and methods: A total of 169 female patients (mean age: 49.6±9.3 years; range, 20 to 76 years) diagnosed with FM were included between June 2023 and November 2023. Based on the Medical Outcome Study Social Support Scale (MOS-SSS), those scoring below the 25 th percentile were categorized as the poor social support group (PSS; n=42) and those above the 25 th percentile as the normal social support group (NSS; n=127). Outcome measures were Visual Analog Scale (VAS), pressure pain threshold (PPTh) and pressure pain tolerance (PPTo), Fibromyalgia Impact Questionnaire (FIQ) and Nottingham Health Profile (NHP) scores. Results: The PSS group had higher FIQ scores (p<0.0001), lower PPTh (p=0.003) and PPTo (p<0.0001) levels, and higher VAS scores (p=0.01). Significant differences were found in the NHP subscales of pain, emotional reaction, social isolation, and sleep in favor of the NSS group. Most types of social support were found to be negatively correlated with VAS and positively correlated with pressure-related pain measurements. Only positive social interaction subscale was not correlated with VAS (r=–0.13, p=0.08), and emotional/informational support subscale was not correlated with PPTh (r=0.14, p=0.06). Conclusion: Our study results suggest that low social support in FM patients is associated with higher pain perception, lower pain threshold, and quality of life.